Denmark won’t use the Johnson & Johnson vaccine, the Danish Well being Authority introduced on Monday, saying in an announcement that the nation may make enough progress utilizing different vaccines and didn’t have to run the chance of a uncommon, harmful blood clotting situation that could be linked to the Johnson & Johnson vaccine.
The nation has halted administering the AstraZeneca vaccine for comparable causes, after two folks died of blood clots after being provided that vaccine.
Denmark had been planning to make use of the Johnson & Johnson single-dose vaccine earlier than stories emerged a couple of attainable hyperlink to the clotting situation, which appears to primarily have an effect on youthful girls. Dropping the vaccine from its plans will set again the nation’s timetable for vaccinating adults beneath 40 by a couple of month, Danish officers mentioned.
The USA quickly suspended utilizing the Johnson & Johnson vaccine, however the Meals and Drug Administration introduced on Friday that it might be made out there once more, with a warning concerning the attainable clotting danger added to its label.
The European Medicines Company, the regulatory physique for the European Union, has additionally endorsed use of the Johnson & Johnson vaccine with an added warning.
The Danish Well being Authority, nevertheless, mentioned it had independently investigated the vaccine and determined in opposition to utilizing it.
“Taking the current scenario in Denmark into consideration, what we’re at present dropping in our effort to forestall extreme sickness from Covid-19 can’t outweigh the chance of inflicting attainable unwanted effects within the type of extreme blood clots in these we vaccinate,” the authority mentioned in an announcement.
“One must also keep in mind that, going ahead, we’ll at the start be vaccinating youthful and wholesome folks,” Helene Probst, the deputy director common of the authority, mentioned within the assertion.
Christina Anderson contributed reporting.